June 2008
AXILICA Limited demonstrates FalconML at Design Automation Conference (DAC) 7th - 14th June 2008, Anaheim, USA. Read more...
18th December 2006
EMDA and e-synergy announce Critical Pharmaceuticals Ltd as the first early stage spin-out company to receive investment from the new East Midlands Early Growth Fund. Please see the press release for details.
23rd January 2006
Quester leads £3.1 million investment in Haemostatix. Please see the press release for the details.
7 November 2005
A new optical instrument that could vastly reduce the amount of time the pharmaceutical industry spends in R&D, by speeding up the measurement of drug inhaler performance, is being launched by Loughborough University spin out VariDose Limited. The details are available at this link.
5 September 2005
Hazid Technologies secures venture capital investment and global alliance agreement. The details are available at this link.
May 2005
Innovative ideas from East Midlands universities are being developed and supported by a range of initiatives in the Region. Monica Healthcare Ltd is the latest example of the real benefits being delivered by these initiatives. Please see EMDA News.
March 2005
A breakthrough hand-held device which could detect the warning signs of heart disease and stroke, could soon be a reality thanks to a £75,000 investment from NESTA (National Endowment for Science, Technology and the Arts), the organisation dedicated to supporting innovators and improving the climate for creativity in the UK. The news was released by NESTA.
15th February 2005
Critical Pharmaceuticals has become the latest company to move into innovation centre BioCity after attracting £750,000 from venture capitalists. University of Nottingham scientists formed Critical Pharmaceuticals to develop an improved way of treating patients with anaemia, growth disorders, cancer and multiple sclerosis. The press release was published on the Nottingham Evening Post.
Website development:
De Facto
De Facto
